johnson  johnson have temporarily paused further dosing in all their covid-19 vaccine candidate clinical trials due to an unexplained illness in a study participant   the participant’s illness is being reviewed and evaluated by their internal clinical and safety physicians pictwittercomz8pucjj2yh